Bridion® (sugammadex) – Case Name: Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 2023-2254, 2025 WL 795317…
Read More →
The Trump Administration recently issued a new Executive Order titled “Modernizing Defense Acquisitions and Spurring Innovation in the Defense Industrial…
Read More →
Eight years ago, on March 1, 2017, the New York Department of Financial Services enacted its landmark cybersecurity regulation covering…
Read More →
Over the past few weeks, I’ve been immersed in the necessary but time-consuming task of updating my Custom GPTs—AI tools…
Read More →
U.S. Digital Asset Companies Announce New Product Launches – A major U.S. cryptocurrency exchange recently announced that certain customers can…
Read More →
The Protection of Lawful Commerce in Arms Act (PLCAA) has long been a cornerstone of protection for firearms manufacturers and…
Read More →
It is becoming almost impossible to avoid being exposed to multiple different chemicals on a daily basis. Companies use them…
Read More →
Resolving a deep split among federal circuit courts, the U.S. Supreme Court has broadened plaintiffs’ ability to sue under the…
Read More →
How prepared is your organization to handle the evolving landscape of sanctions compliance? In this episode of Corruption, Crime and…
Read More →
Invega Trinza® (paliperidone palmitate) – Case Name: Janssen Pharms., Inc. v. Mylan Labs. Ltd., No. 2023-2042, 2025 WL 946390 (Fed.…
Read More →